Authors
Advertisement
Advertisement
Trending on HCPLive
1
RELIEVE-AD-PEDs: Dupilumab Sustains Adolescent Atopic Dermatitis Control at 1 Year
2
Remibrutinib Receives FDA Approval for Symptomatic Dermographism
3
Targeting the Disease Mechanism in PFIC, With Hisamitsu Hayashi, PhD
4
Top Reason for Leaving HAE Attacks Untreated, Survey Finds
5
